Physician profile
Rupam Das
NPI 1073834768
$14,847.56
in general payments reported to CMS, 2019-2025
27 companies · $6,151 in 2025
The $6,151 reported for 2025 was more than what 83% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,182 · 2020: $201 · 2021: $290 · 2022: $4,054 · 2023: $2,400 · 2024: $569 · 2025: $6,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,393 · Food and Beverage: $3,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,393.25 |
| Food and Beverage | $3,727.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,965.41 | 2019-2025 | |
| Novus Surgical Consultants | $2,289.47 | 2023-2025 | |
| Novus Surgical Solutions LLC | $2,273.01 | 2021-2022 | |
| Stryker Corporation | $1,608.08 | 2020-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Mako |
| Depuy Synthes Sales INC. | $966.32 | 2023-2025 | Inhance, Monovisc, Orthovisc |
| Medical Device Business Services, INC. | $323.50 | 2022-2025 | Inhance, Reclaim |
| Ermi LLC | $196.96 | 2019-2025 | |
| Abbott Laboratories | $145.15 | 2025 | Proclaim |
| Sanara Medtech INC. | $139.94 | 2025 | Biasurge |
| Zimmer Biomet Holdings, INC. | $104.80 | 2023 | Tapestry |
| Linvatec Corporation | $97.53 | 2024 | Biobrace 23mm |
| Arthrosurface Incorporated | $96.19 | 2020 | |
| Ferring Pharmaceuticals INC. | $90.38 | 2023-2025 | Euflexxa |
| Horizon Therapeutics Plc | $83.02 | 2021-2022 | |
| Dynasplint Systems INC. | $67.92 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $55.53 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $50.44 | 2025 | |
| Janssen Biotech, INC. | $47.44 | 2022-2023 | Tremfya |
| Skeletal Dynamics INC | $46.81 | 2019 | |
| Averitas Pharma INC. | $41.32 | 2023-2025 | Qutenza |
| Tersera Therapeutics LLC | $38.38 | 2025 | Prialt |
| Bioventus LLC | $35.14 | 2022-2023 | Stimrouter Implantable Kit |
| Pacira Pharmaceuticals Incorporated | $30.25 | 2023 | Exparel, Zilretta, Iovera |
| Solventum Corporation | $19.64 | 2025 | Activ.A.C. |
| Smith+Nephew, INC. | $14.60 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.00 | 2022 | |
| Orthofix Medical, INC. | $7.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupam Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.